Tales Fernando da Silva

Tales Fernando da Silva

Auto-generated profile, based on publicly available information

Tales Fernando da Silva

Escola de Veterinária, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270901, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
VBViviane Lima Batista
Viviane Lima Batista
TSTales Fernando da Silva
Tales Fernando da Silva
LJLuís Cláudio Lima de Jesus
Luís Cláudio Lima de Jesus
NRNina Coelho Rocha
Nina Coelho Rocha
FBFernanda Alvarenga Lima Barroso
Fernanda Alvarenga Lima Barroso
MDMariana Drumond
Mariana Drumond
Intestinal mucositis, a cytotoxic side effect of the antineoplastic drug 5-fluorouracil (5-FU), is characterized by ulceration, inflammation, diarrhea, and intense abdominal pain, making it an important issue for clinical medicine. Given the seriousness of the problem, therapeutic alternatives have been sought as a means to ameliorate, prevent, and treat this condition. Among the alternatives available to address this side effect of treatment with 5-FU, the most promising has been the use of probiotics, prebiotics, synbiotics, and paraprobiotics. This review addresses the administration of these “biotics” as a therapeutic alternative for intestinal mucositis caused by 5-FU. It describes the effects and benefits related to their use as well as their potential for patient care.

30 May 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MCMayara Medeiros de Freitas Carvalho
Mayara Medeiros de Freitas Carvalho
NLNara Nunes Lage
Nara Nunes Lage
APAlice Helena de Souza Paulino
Alice Helena de Souza Paulino
RPRenata Rebeca Pereira
Renata Rebeca Pereira
LALetícia Trindade de Almeida
Letícia Trindade de Almeida
JGJoyce Guerra
Joyce Guerra
Non-alcoholic fatty liver disease (NAFLD), the most predominant liver disease worldwide, is a progressive condition that encompasses a spectrum of disorders ranging from steatosis to steatohepatitis, and, ultimately, cirrhosis and hepatocellular carcinoma. Although the underlying mechanism is complex and multifactorial, several intracellular events leading to its progression have been identified, including oxidative stress, inflammation, mitochondrial dysfunction, apoptosis, and altered endoplasmic reticulum (ER) homeostasis. Phenolic compounds, such as those present in açai (Euterpe oleracea Mart.), are considered promising therapeutic agents due to their possible beneficial effects on the prevention and treatment of NAFLD. We tested in vitro effects of aqueous açai extract (AAE) in HepG2 cells and its influence on oxidative stress, endoplasmic reticulum stress, and inflammation in a murine model of high fat diet-induced NAFLD. In vitro AAE exhibited high antioxidant capacity, high potential to inhibit reactive oxygen species production, and no cytotoxicity. In vivo, AAE administration (3 g/kg) for six weeks attenuated liver damage (alanine aminotransferase levels), inflammatory process (number of inflammatory cells and serum TNFα), and oxidative stress, through the reduction of lipid peroxidation and carbonylation of proteins determined by OxyBlot and modulation of the antioxidant enzymes: glutathione reductase, SOD and catalase. No change was observed in collagen content indicating an absence of fibrosis, stress-related genes in RE, and protein expression of caspase-3, a marker of apoptosis. With these results, we provide evidence that açai exhibits hepatoprotective effects and may prevent the progression of liver damage related to NAFLD by targeting pathways involved in its progression.

1 October 2018 in Antiviral Research
Verified
Journal Article
Closed access
FCFernanda Caetano Camini
Fernanda Caetano Camini
TSTales Fernando da Silva
Tales Fernando da Silva
CCCamila Carla da Silva Caetano
Camila Carla da Silva Caetano
LALetícia Trindade Almeida
Letícia Trindade Almeida
AFAriane Coelho Ferraz
Ariane Coelho Ferraz
CMCíntia Lopes de Brito Magalhães
Cíntia Lopes de Brito Magalhães

20 October 2021 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
QDQuésia S. Damaceno
Quésia S. Damaceno
BGBruno Gallotti
Bruno Gallotti
IRIsabela M. M. Reis
Isabela M. M. Reis
YTYasmim C. P. Totte
Yasmim C. P. Totte
GAGabriella B. Assis
Gabriella B. Assis
FMFlaviano Martins
Flaviano Martins

1 November 2020 in Acta Tropica
Verified
Journal Article
Closed access
TSTales Fernando da Silva
Tales Fernando da Silva
AFAriane Coelho Ferraz
Ariane Coelho Ferraz
LALetícia Trindade Almeida
Letícia Trindade Almeida
CCCamila Carla da Silva Caetano
Camila Carla da Silva Caetano
FCFernanda Caetano Camini
Fernanda Caetano Camini
CMCíntia Lopes de Brito Magalhães
Cíntia Lopes de Brito Magalhães

25 October 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CCCamila Carla da Silva Caetano
Camila Carla da Silva Caetano
FCFernanda Caetano Camini
Fernanda Caetano Camini
LALetícia Trindade Almeida
Letícia Trindade Almeida
AFAriane Coelho Ferraz
Ariane Coelho Ferraz
TSTales Fernando da Silva
Tales Fernando da Silva
CMCíntia Lopes de Brito Magalhães
Cíntia Lopes de Brito Magalhães
Mayaro virus (MAYV) causes Mayaro fever in humans, a self-limiting acute disease, with persistent arthralgia and arthritis. Although MAYV has a remerging potential, its pathogenic mechanisms remain unclear. Here, we characterized a model of MAYV infection in 3–4-week BALB/c mice. We investigated whether the liver acts as a site of viral replication and if the infection could cause histopathological alterations and an imbalance in redox homeostasis, culminating with oxidative stress. MAYV-infected mice revealed lower weight gain; however, the disease was self-resolving. High virus titre, neutralizing antibodies, and increased levels of aspartate and alanine aminotransferases were detected in the serum. Infectious viral particles were recovered in the liver of infected animals and the histological examination of liver tissues revealed significant increase in the inflammatory infiltrate. MAYV induced significant oxidative stress in the liver of infected animals, as well as a deregulation of enzymatic antioxidant components. Collectively, this is the first study to report that oxidative stress occurs in MAYV infection in vivo, and that it may be crucial in virus pathogenesis. Future studies are warranted to address the alternative therapeutic strategies for Mayaro fever, such as those based on antioxidant compounds.